NYSE:HIMS Hims & Hers Health (HIMS) Stock Price, News & Analysis $32.69 -2.35 (-6.72%) As of 11:54 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Hims & Hers Health Stock (NYSE:HIMS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Hims & Hers Health alerts:Sign Up Key Stats Today's Range$31.75▼$33.8950-Day Range$25.41▼$51.3752-Week Range$11.20▼$72.98Volume22.01 million shsAverage Volume16.34 million shsMarket Capitalization$7.28 billionP/E Ratio74.50Dividend YieldN/APrice Target$36.92Consensus RatingHold Company OverviewHims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Read More… Hims & Hers Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks64th Percentile Overall ScoreHIMS MarketRank™: Hims & Hers Health scored higher than 64% of companies evaluated by MarketBeat, and ranked 240th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingHims & Hers Health has received a consensus rating of Hold. The company's average rating score is 2.08, and is based on 3 buy ratings, 8 hold ratings, and 2 sell ratings.Amount of Analyst CoverageHims & Hers Health has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Hims & Hers Health's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth79.31% Earnings GrowthEarnings for Hims & Hers Health are expected to grow by 79.31% in the coming year, from $0.29 to $0.52 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hims & Hers Health is 73.61, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.64.Price to Earnings Ratio vs. SectorThe P/E ratio of Hims & Hers Health is 73.61, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.34.Price to Book Value per Share RatioHims & Hers Health has a P/B Ratio of 20.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Hims & Hers Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted33.32% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hims & Hers Health has recently increased by 5.00%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHims & Hers Health does not currently pay a dividend.Dividend GrowthHims & Hers Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted33.32% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hims & Hers Health has recently increased by 5.00%, indicating that investor sentiment is decreasing. News and Social Media3.2 / 5News Sentiment0.68 News SentimentHims & Hers Health has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 35 news articles for Hims & Hers Health this week, compared to 21 articles on an average week.Search Interest115 people have searched for HIMS on MarketBeat in the last 30 days. This is an increase of 11% compared to the previous 30 days.MarketBeat Follows36 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is an increase of 44% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Hims & Hers Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $27,992,450.00 in company stock.Percentage Held by Insiders17.71% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Hims & Hers Health's insider trading history. Receive HIMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter. Email Address HIMS Stock News HeadlinesHims & Hers Stock Soars on Novo Nordisk CollaborationHims & Hers stock rallies by over 25% on news of a collaboration with Novo Nordisk and its weight loss flagship products, and that's not all.April 30 at 10:38 AM | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Irene Becklund Sells 2,936 SharesApril 24, 2025 | insidertrades.comTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 30, 2025 | Porter & Company (Ad)Hims & Hers Health, Inc. (NYSE:HIMS) CEO Sells $1,022,338.40 in StockApril 19, 2025 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Soleil Boughton Sells 3,236 SharesApril 17, 2025 | insidertrades.comWegovy Today, Ozempic Tomorrow: Partnership With Novo Is Hims & Hers ComebackApril 29 at 8:39 PM | seekingalpha.comHims & Hers Health: GLP-1 Deals De-Risk The StoryApril 29 at 8:39 PM | seekingalpha.comTD Cowen downgrades Hims & Hers Health to Hold on GLP-1 headwinds,April 29 at 3:38 PM | finance.yahoo.comSee More Headlines HIMS Stock Analysis - Frequently Asked Questions How have HIMS shares performed this year? Hims & Hers Health's stock was trading at $24.18 at the beginning of 2025. Since then, HIMS shares have increased by 33.2% and is now trading at $32.2150. View the best growth stocks for 2025 here. How were Hims & Hers Health's earnings last quarter? Hims & Hers Health, Inc. (NYSE:HIMS) posted its quarterly earnings results on Monday, February, 24th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.02. The firm earned $481.14 million during the quarter, compared to the consensus estimate of $494.56 million. Hims & Hers Health had a net margin of 8.19% and a trailing twelve-month return on equity of 10.97%. Read the conference call transcript. Who are Hims & Hers Health's major shareholders? Top institutional investors of Hims & Hers Health include Yong Rong HK Asset Management Ltd (1.08%), Bank of New York Mellon Corp (0.57%), IMC Chicago LLC and Principal Financial Group Inc. (0.36%). Insiders that own company stock include Melissa Baird, David B Wells, Alex Bard, Patrick Harrison Carroll, Michael Chi, Soleil Boughton, Jules A Maltz, Oluyemi Okupe, Christopher D Payne, Andrew Dudum, Christiane Pendarvis, Irene Becklund, Irene Becklund, Anja Manuel and Lynne Chou O'keefe. View institutional ownership trends. How do I buy shares of Hims & Hers Health? Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Hims & Hers Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Hims & Hers Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX) and Palo Alto Networks (PANW). Company Calendar Last Earnings2/24/2025Today4/29/2025Next Earnings (Estimated)5/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Offices & clinics of medical doctors Sub-IndustryHealthcare Current SymbolNYSE:HIMS CIK1773751 Webwww.forhims.com Phone415-851-0195FaxN/AEmployees650Year FoundedN/APrice Target and Rating Average Stock Price Target$36.92 High Stock Price Target$68.00 Low Stock Price Target$23.00 Potential Upside/Downside+5.2%Consensus RatingHold Rating Score (0-4)2.08 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)$0.54 Trailing P/E Ratio79.73 Forward P/E Ratio120.97 P/E GrowthN/ANet Income$-23,550,000.00 Net Margins8.19% Pretax Margin4.16% Return on Equity10.97% Return on Assets8.29% Debt Debt-to-Equity RatioN/A Current Ratio2.14 Quick Ratio1.82 Sales & Book Value Annual Sales$1.48 billion Price / Sales5.28 Cash FlowN/A Price / Cash FlowN/A Book Value$1.61 per share Price / Book21.79Miscellaneous Outstanding Shares222,166,000Free Float179,786,000Market Cap$7.79 billion OptionableOptionable Beta1.65 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NYSE:HIMS) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredYou’re About to Lose Everything – Act Now or Regret It ForeverWhat If America's Gold Reserves Are a Lie? For decades, the U.S. government has claimed to have thousands o...Hamilton Gold Group | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.